|
SENP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.045799973871E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7582000000349E-07 |
| Normal-vs-Stage2 |
2.012200E-04 |
| Normal-vs-Stage3 |
5.39680000688492E-09 |
| Normal-vs-Stage4 |
4.4710000035586E-08 |
| Stage1-vs-Stage2 |
9.131200E-01 |
| Stage1-vs-Stage3 |
1.315810E-01 |
| Stage1-vs-Stage4 |
5.673900E-02 |
| Stage2-vs-Stage3 |
3.603200E-01 |
| Stage2-vs-Stage4 |
1.731010E-01 |
| Stage3-vs-Stage4 |
4.441400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11739995034554E-09 |
| Normal-vs-AfricanAmerican |
2.584000E-01 |
| Normal-vs-Asian |
3.25459999994671E-06 |
| Caucasian-vs-AfricanAmerican |
3.299600E-03 |
| Caucasian-vs-Asian |
8.510000E-01 |
| AfricanAmerican-vs-Asian |
8.900200E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73509984158216E-10 |
| Normal-vs-Female |
7.58560000369002E-08 |
| Male-vs-Female |
7.193900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.21669999997298E-06 |
| Normal-vs-Age(41-60Yrs) |
1.37719999848684E-08 |
| Normal-vs-Age(61-80Yrs) |
2.31809999973187E-07 |
| Normal-vs-Age(81-100Yrs) |
1.083860E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.284400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.464600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.789000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.810200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.635200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.742000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.082200E-03 |
| Classical-VS-Follicular |
4.314600E-01 |
| Classical-VS-Other |
7.341600E-01 |
| Classical-VS-Normal |
6.49459996893142E-09 |
| Tall-VS-Follicular |
5.341300E-03 |
| Tall-VS-Other |
5.594000E-01 |
| Tall-VS-Normal |
2.5630999545001E-09 |
| Follicular-VS-Other |
6.201600E-01 |
| Follicular-VS-Normal |
5.440200E-04 |
| Other-VS-Normal |
2.557700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.0087999996754E-07 |
| Normal-vs-N1 |
3.52100000267086E-08 |
| N0-vs-N1 |
6.422200E-02 |
|
|
